Pfizer Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Pfizer key operating metrics including Phase I Trials Products, environmental, and social and governance score (ESG).

Phase I Trials Products

24.4%

FY, 2024

Phase III Trials Products

3.2%

FY, 2024

Properties

251

11.6%

FY, 2024

Operating Metrics

Metrics	FY, 2022	FY, 2023	FY, 2024
Phase I Trials Products	34	41	51
Phase III Trials Products	23	31	32
Properties	310	284	251
Manufacturing Sites	36	37	37
Countries	185	200	200
R&D Projects	110	112	115
Registration Phase Products	16	6	5
Phase II Trials Products	37	34	27

50-59 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub